UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Medline ® Abstract for Reference 38

of 'Direct-acting antivirals for the treatment of hepatitis C virus infection'

38
TI
Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated variants (RAVs) after treatment with grazoprevir-containing regimens in patients with chronic hepatitis C virus (HCV) infection
AU
Lahser F, Galloway A, Hwang P, et al
SO
Hepatology. 2016;64:32A.
 
AD